UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000009910
Receipt No. R000011612
Scientific Title A phaseII study of irinotecan with bevacizumab as third line treatment for patients with metastatic colorectal cancer after failure to irinotecan who have progressed on bevacizumab with oxaliplatin-based chemotherapy in second line.
Date of disclosure of the study information 2013/01/30
Last modified on 2018/08/14 01:15:14

No. Disposal Last modified on Item of update
1 Insert 2013/01/30 20:38:49
2 Update 2013/05/30 11:03:01 Key inclusion criteria
Key inclusion criteria
3 Update 2018/08/14 01:15:14 Recruitment status

Contact us.